T1	Participants 60 116	men treated for symptomatic benign prostatic hyperplasia
T2	Participants 224 313	men with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
T3	Participants 373 397	men aged > or = 50 years
T4	Participants 690 702	372 patients
